Study unveils new hope for MS patients

Language: English

Welcome to EPG Patient Direct

World Psoriasis Day - 2008

More News Health News

New study produces unlimited insulin cells for diabetes treatment
Published Friday 21 November 2008
Doctor warns of premature birth risk
Published Thursday 20 November 2008
Public warned over vaccination importance
Published Thursday 20 November 2008
New strategies to help marginalised communities
Published Wednesday 19 November 2008

Your Vote

Would you like your employer to provide better access to healthy foods?

Tools and Links

Find Out More About

This service contains links to third party websites. EPG Patient Direct is not in a position to verify this information and cannot be held responsible for the accuracy of the content contained.

More NewsEPG Patient Direct News

23 Jun 2008

A new international trial has discovered a promising alternative treatment for patients living with multiple sclerosis (MS).

The study led by Italian expert professor Giancarlo Comi, from the University Vita-Salute in Milan, showed that a new pill could offer MS sufferers an alternative treatment to injected drugs.

Results showed that a daily dose of laquinimod reduced signs of MS inflammation by more than 40 per cent.

In contrast to existing methods of treating MS, the new medication can be taken orally rather than being injected, making it more convenient for patients.

Published in the Lancet Medical Journal, the report stated that the overall effectiveness and safety demonstrated by the trial, "in combination with the oral route for administration, make laquinimod a promising therapeutic opportunity for patients" with multiple sclerosis.

Researchers are now conducting further assessments of the benefits and risks of the new treatment on a larger scale.

Click here to visit the Multiple Sclerosis Quick Guide ADNFCR-1528-ID-18650808-ADNFCR

E-mail Bookmark Print

Delicious Reddit Facebook StumbleUpon